Dr Freddy Yip
Dr. Freddy Yip, Associate at Cooley, focuses his practice on licensing, collaboration, joint venture, and complex IP transactions in life sciences, with expertise in cross-border deals, clinical trials, manufacturing agreements, and equity financings. He holds a PhD in molecular cell biology from the University of New South Wales and brings prior R&D experience from biopharma roles in Australia and Hong Kong, specialising in CMC and preclinical development of protein-based drugs like anti-cancer antibodies.
Contact Information:
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation
Hong Kong should build the Asia–Latin America investment corridor
Why Hong Kong's carried interest reform matters, and why it isn't a zero-sum play